Salenger Sack Kimmel & Bavaro logo

Oxbryta VOC Lawsuits

DON'T WAIT!
GET HELP NOW.
Call (800) 675-8556 or fill out this form for a FREE Consultation
Consent

Oxbryta Lawsuit Attorneys: Legal Help for Sickle Cell Drug Injuries

Several white tablets are scattered on a reflective surface beside an open prescription pill bottle, with another bottle lying on its side in the background.

Have You or a Loved One Suffered Severe Side Effects or Death After Taking Oxbryta?

You may be eligible to file an Oxbryta lawsuit and seek compensation for medical bills, pain and suffering, or wrongful death. The law firm of Salenger, Sack, Kimmel & Bavaro, LLP is now representing sickle cell patients and families impacted by the defective prescription drug Oxbryta (voxelotor)—a medication linked to increased vaso-occlusive crises (VOCs), stroke, and death.


Oxbryta: A Dangerous Drug Marketed for Sickle Cell Treatment

Oxbryta is a sickle cell medication first developed by Global Blood Therapeutics and later acquired by Pfizer, Inc. Approved by the FDA in 2019 under an accelerated pathway, Oxbryta was designed to prevent red blood cells from sickling and reduce the risk of complications from sickle cell disease (SCD). In 2021, its approval was expanded for children as young as 4.

However, new post-marketing studies and clinical trial data revealed alarming results: patients taking Oxbryta experienced higher rates of VOCs and fatalities compared to the placebo group. This led to a voluntary recall of the drug in September 2024.

What Is Oxbryta?

Oxbryta is a medication originally developed by Global Blood Therapeutics (GBT) and later acquired by Pfizer, Inc. It was fast-tracked for FDA approval in 2019 for treating sickle cell disease (SCD) in adults and children 12 years and older. By 2021, the approval was expanded to include children ages 4 to 11.

The drug was intended to work by preventing red blood cells from sickling, improving oxygen delivery, and reducing the frequency of painful vaso-occlusive episodes. However, new data from Pfizer’s ongoing clinical trials has shown that Oxbryta may increase the very complications it was designed to prevent.


Oxbryta FDA Recall & Safety Concerns

On September 26, 2024, Pfizer issued a voluntary global recall of Oxbryta. The FDA published a safety communication confirming that clinical trial participants taking Oxbryta had increased risks of vaso-occlusive crisis events, decreased oxygen delivery, and death. Pfizer admitted in its statement that the “benefits no longer outweigh the risks.”


What Is a Vaso-Occlusive Crisis (VOC)?

VOCs are painful, dangerous events in sickle cell patients where misshapen red blood cells block blood vessels, cutting off oxygen supply to vital organs.

VOC symptoms include:

  • Sudden pain in the chest, back, arms, or legs

  • Swelling in hands and feet (especially in children)

  • Fatigue or shortness of breath

  • Fever, stroke risk, or acute chest syndrome


Oxbryta Lawsuit Update

June 16, 2025 — Wrongful Death Lawsuit Filed
A widow in Tennessee filed a wrongful death lawsuit in Northern District of California against Pfizer and Global Blood Therapeutics, alleging that her husband died from complications caused by Oxbryta, including increased VOCs and stroke. He began using Oxbryta in 2022, suffered a stroke in April 2024, and died in May 2024.

July 1, 2025 — Potential MDL in Discussion
Attorneys are monitoring whether Oxbryta lawsuits will be consolidated into a multidistrict litigation (MDL). While an MDL could streamline proceedings, some legal experts caution that it may reduce individual settlement values.


Contact Us Today for a FREE Consultation

If you or a loved one has experienced complications from Oxbryta, don’t wait to seek legal help.

Contact Salenger, Sack, Kimmel & Bavaro today for a FREE consultation.

Call (800) 675-8556 or contact us online to get started. 

Why Are Oxbryta Lawsuits Being Filed?

Patients and families are pursuing Oxbryta product liability claims for the following reasons:

  • The drug caused vaso-occlusive crises, strokes, and deaths

  • Pfizer and GBT failed to warn about the true risks

  • The drug did not undergo adequate long-term testing

  • Post-market surveillance failed to protect patients

  • The drug was still marketed after known safety issues emerged


Who Is Eligible to File an Oxbryta Lawsuit?

You may qualify if:

  • You or a loved one took Oxbryta for sickle cell anemia

  • You suffered a VOC, stroke, hospitalization, or death

  • You have medical records linking your injury to the medication

  • You are the surviving family member of someone who died while using Oxbryta


Compensation in an Oxbryta Lawsuit

If successful, your case may result in compensation for:

  • Past and future medical expenses

  • Hospitalization and emergency care

  • Loss of income or reduced earning ability

  • Pain and suffering

  • Wrongful death damages (if applicable)

  • Punitive damages if corporate misconduct is proven


Speak With an Experienced Dangerous Drug Lawyer

Salenger, Sack, Kimmel & Bavaro is a nationally recognized law firm with extensive experience in pharmaceutical lawsuits, including recalled medications, defective drug litigation, and wrongful death claims. We are currently reviewing claims from across the U.S. related to the Oxbryta recall and its devastating side effects.

Why clients choose SSKB:

  • Decades of success in mass tort and personal injury cases

  • Partnerships with leading medical experts and toxicologists

  • No upfront fees – we only get paid if you win

  • Personalized, compassionate legal guidance


What to Do If You Took Oxbryta

To protect your legal rights:

  1. Save medical records showing diagnosis, prescriptions, and treatment

  2. Document all symptoms, VOCs, or complications

  3. Call (800) 675-8556 or fill out our online form for a free consultation


Frequently Asked Questions (FAQs)

Is Oxbryta still on the market?
No. Oxbryta was recalled in September 2024 and is no longer available.

Can I file on behalf of someone who died?
Yes. Wrongful death lawsuits are available to surviving spouses, children, or legal representatives.

Is this part of a class action?
Not yet. Oxbryta lawsuits are being filed individually, though future consolidation is possible.

Is there a time limit to file?
Yes. Each state has a statute of limitations, so act quickly to protect your claim.


Start Your Oxbryta Lawsuit Today

If Oxbryta caused serious harm or death to you or a loved one, don’t wait to take legal action. Our drug injury lawyers are here to fight for the justice and compensation you deserve.

📞 Call (800) 675-8556 or fill out our secure form to schedule your free consultation.

Let our experienced team of Oxbryta recall attorneys help you move forward with confidence.

 

What Our Clients Are Saying

“The SSKB law firm made the right decision in adding you to their expert team of lawyers. In the future, there isn’t any other firm that I would consider to represent me.”

Jim W.

“Thank you Deborah Kurtz for being my attorney and fighting for me!”

Edwin S.

“Deborah Kurtz is a straight shooter and plays no games all while maintaining the highest level of professionalism.”

Joe M.

“I had them for a case that was very difficult this firm was the best very caring and concerned I was treated like family.”

Robbie J.

“I would highly recommend them due to the fact that during a difficult time, they made the process very straightforward with excellent results.”

Ciara L.

“This being a FELA case it was a very difficult case to handle. This firm came highly recommended to me and I now I know why.”

Joseph B.

“We were so fortunate to find this firm through a recommendation and now we have used them twice for unrelated matters. They have become our “lawyers for life”!”

Dublinshar K.

“Everyone at Salenger, Sack, Kimmel, and Bavaro was respectful and knowledgeable and kept me informed of all proceedings relative to my case as they were occurring.”

Patricia F.
Call Me
We'll call you!
Consent*
Email Us
Send any details you'd like, and we'll get back to you shortly.
Consent*